8 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Murmurs Needing Echocardiography Evaluation #Management #EM #IM #Cardiology #Murmur #Benign #Characteristics #Echocardiogram #ALiEM
Echocardiography Evaluation #Management ... #EM #IM #Cardiology
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... AdverseEvents #NEJM ... #NEJM
Algorithm for the Evaluation and Management of NSVT #Diagnosis #Management #EM #IM #Cardiology #NSVT #Evaluation #NonSustained
Evaluation and Management ... NSVT #Diagnosis #Management ... #EM #IM #Cardiology
If the choice is available, biphasic waveform devices have greater efficacy than monophasic.In terms of the
#Management #EBM ... #EM #IM #Cardiology
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (RE-DUAL PCI trial) - Shown is
warfarin (Panel A) #EBM ... #Cardiology #IM ... AtrialFibrillation #NEJM
Table of Common Rate Control Agents via AHA/ACC/HRS Guidelines #Management #Pharm #EM #IM #Cardiology #Afib #Common
HRS Guidelines #Management ... #Pharm #EM #IM ... #Cardiology #Afib